A new prognostic tool for CLL: CLL-IPI
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Empowering CLL patients: Do physicians need more communication skills training?
Can concepts from CLL be applied to other liquid and solid tumors?
Ibrutinib vs chlorambucil in CLL patients not suitable for chemotherapy